Markets:

Overview

News

Currencies

International

Treasuries

Incannex Healthcare Inc. - Common Stock (NQ:IXHL)

0.3555 +0.0055 (+1.57%)

Streaming Delayed Price Updated: 10:26 AM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Incannex Healthcare Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 08, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 08, 2022

We're starting off the day with a look at the biggest pre-market stock movers that traders will want to watch on Thursday!

Via InvestorPlace

Incannex Files A Provisional Patent Application Of Its THC-Based IHL-42X For The Treatment Of Obstructive Sleep Apnea ↗

December 06, 2022

Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL), announced the filing of a provisional patent application directed to the use of IHL-42X for the treatment of obstructive sleep apnea (‘OSA’).

Via Benzinga

Eurofins To Produce Incannex' 2 CBD Medicated Chews For Treatment Of Nicotine And Opioid Addiction Disorders ↗

November 28, 2022

Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has engaged multinational contract development and manufacturing organization Eurofins Scientific (OTCPK:ERFSF) to manufacture Incannex’s two...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

April 08, 2022

During Friday's morning session, 234 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company in terms of market cap...

Via Benzinga

Incannex Initiates BA/BE Clinical Trial Evaluating IHL-42X In Obstructive Sleep Apnoea ↗

November 17, 2022

Cannabis and psychedelics-focused Pharma company Incannex Healthcare Limited (NASDAQ: IXHL) (ASX: IHL) initiated a BA/BE study and is targeting submission of an IND application with the FDA in Q1...

Via Benzinga

A Global List Of Cannabis Operators And Executives To Keep An Eye On In 2022 And Beyond ↗

November 09, 2022

Less than 30 years after Israel became the first nation in the world to allow its citizens to use cannabis for medical purposes, the medical and adult-use cannabis markets have spread across the globe...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 04, 2022

Gainers Incannex Healthcare (NASDAQ:IXHL) shares moved upwards by 30.7% to $5.19 during Friday's pre-market session. The market value of their outstanding shares is at $316.2 million.

Via Benzinga

Australian Psychedelics: Incannex Business & Financials, New Research Center For Mushrooms & Eating Disorders ↗

October 28, 2022

Clinical-stage biopharma company Incannex Healthcare Ltd. (NASDAQ: IXHL) shared its quarterly activities report and appendix 4C for the period ended 30 September 2022, noticeably applying for several...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

October 13, 2022

Good morning, investor! We're starting off Thursday with a breakdown of the biggest pre-market stock movers this morning!

Via InvestorPlace

Unrivaled Brands & Other Cannabis Operators Just Made Some Key Executive Changes You Should Know About ↗

August 19, 2022

As Benzinga Cannabis Capital Conference returns on September 13-14 to Chicago, gathering top CEOs, investors and leaders in the industry, let's scroll through the latest leadership changes within the...

Via Benzinga

Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert ↗

August 17, 2022

Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) appointed pharmaceutical executive Robert B. Clark to the board of directors.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 22, 2022

Via Benzinga

Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday ↗

August 08, 2022

Gainers

Via Benzinga

Incannex Approved To Commence Phase 1 Clinical Trial Of CBD Based Anti-Inflammatory Drug ↗

July 21, 2022

Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has received approval from the Bellberry Human Research Ethics Committee ('HREC') for a phase 1 clinical trial investigating its proprietary...

Via Benzinga

Incannex Reveals Clinical Trial Results On Dronabinol-Based Drug For Obstructive Sleep Apnea ↗

June 03, 2022

Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL), a clinical-stage pharmaceutical company developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for unmet...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 03, 2022

Via Benzinga

Incannex Announces Positive Pre-IND Meeting with U.S. FDA for IHL-42X for Obstructive Sleep Apnoea: Incannex Healthcare Limited (NASDAQ: IXHL)

May 24, 2022

Via Get News

Advancements for Anxiety, Sleep Apnea, Brain Injury, Lung Inflammation, Rheumatoid Arthritis & Inflammatory Bowel Disease: Incannex Healthcare Limited (NASDAQ: IXHL)

May 05, 2022

Via Get News

Topics Intellectual Property

Advancements for Anxiety, Sleep Apnea, Brain Injury, Lung Inflammation, Rheumatoid Arthritis & Inflammatory Bowel Disease: Incannex Healthcare Limited (NASDAQ: IXHL)

May 05, 2022

Via Viz Release

Topics Intellectual Property

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 27, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

March 31, 2022

On Thursday, 92 companies hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 30, 2022

On Wednesday, 29 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 29, 2022

On Tuesday, 81 stocks hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Grupo Aval Acciones (NYSE:AVAL) was the biggest company by market cap to set a...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

March 28, 2022

On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

Incannex Healthcare To Acquire APIRx Pharmaceuticals For $93.3M ↗

March 24, 2022

Incannex Healthcare Limited (NASDAQ:IXHL) (ASX: IHL) annou...

Via Benzinga

20 Stocks Moving in Thursday's Pre-Market Session ↗

March 24, 2022

Gainers Mercurity Fintech Holding Inc. (NYSE: MFH) rose 91% to $4.03 in pre-market trading. Energy Services of America Corporation (NASDAQ: ESOA) shares rose 40% to $4.62 in pre-...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 16, 2022

Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 114.0% to $0.59 during Wednesday's regular session. As of 13:30 EST, this security is trading at a volume of...

Via Benzinga

64 Biggest Movers From Yesterday ↗

March 18, 2022

Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:...

Via Benzinga

80 Biggest Movers From Yesterday ↗

March 17, 2022

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares gained 86.7% to close at $0.5150 on Wednesday after the company announced FDA clearance of its IND for SON-...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Incannex Healthcare Inc. - Common Stock (NQ:IXHL)

All News about Incannex Healthcare Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today